Low awareness but high acceptability of pre-exposure prophylaxis for HIV among men who have sex with men and transgender persons in Delhi,India

Abstract

Background: HIV pre-exposure prophylaxis (PrEP) is part of India’s HIV prevention policy. We aimed to determine awareness of and willingness-to-use PrEP among men-who-have-sex-with-men (MSM) and transgender-persons (TG) in Delhi, India.

Methods: A cross-sectional study was conducted at five purposively selected targeted-intervention projects in Delhi. Participants included self-identified MSM/TG aged ≥18 years, with negative/unknown HIV serostatus. A structured interview schedule, developed using formative research, was used. Primary outcomes were awareness of, and willingness-to-use PrEP. Socio-demographic and behaviour variables included age, living situation, education, anal-sex, condom-use and experiences of physical-violence. Determinants of outcome were identified in univariable logistic regression; variables associated at p < .25 were included in multivariable regression models.

Results: Of 400 (224 MSM, 176 TG), mean ± SD age 25.7 ± 7.2 years, 14.5% (95% CI 11.0, 18.0) were aware of PrEP, while 63.3% (95% CI: 58.6, 68.1) reported willingness-to-use PrEP. PrEP-awareness was independently associated with formal-education (adjusted odds ratio; AOR = 1.20), professional occupation (AOR = 5.45) and condom-use (AOR = 3.07). Willingness-to-use PrEP was higher if participants had recent anal-sex (AOR = 2.29), had used condoms during anal-sex (AOR = 2.09), or recently experienced physical-violence (AOR = 3.65).

Conclusions: PrEP awareness was low, but most were willing to use PrEP, implying that communication is key to PrEP awareness and uptake.

Keywords

Awareness acceptability pre-exposure prophylaxis men who have sex with men transgender persons India prevalence

Get full access to this article

View all access options for this article.

References

National AIDS Control Organization , ICMR-National Institute of Medical Statistics . India HIV Estimates 2021: Fact Sheet. New Delhi: NACO, Ministry of Health and Family Welfare, Government of India. Available from: https://naco.gov.in/sites/default/files/India_HIV_Estimates_2021__Fact%20Sheets__Final_Shared_24_08_2022_0.pdf (2022, accessed 21 October 2022).

National AIDS Control Organisation . Sankalak: status of national AIDS response. 4th ed. New Delhi: NACO, Ministry of Health and Family Welfare, Government of India, p. 361. Available from: http://naco.gov.in/sites/default/files/Sankalak_Report_1.pdf (2022, accessed 28 February 2023)

Chou

Evans

Hoverman

, et al. Preexposure prophylaxis for the prevention of HIV infection: evidence report and systematic review for the US preventive services task force. JAMA 2019; 321(22): 2214–2230.

World Health Organization . Guidelines on long-acting injectable cabotegravir for HIV prevention. Geneva: World Health Organization. Available from: https://apps.who.int/iris/handle/10665/360869 (2022, accessed 21 October 2022).

National Technical Guidelines for pre-exposure prophylaxis. New Delhi: NACO, Ministry of Health and Family Welfare, Government of India, p. 58. Available from: http://naco.gov.in/sites/default/files/National_Technical_Guidelines_(Web).pdf (2021, accessed 25 July 2022).

Datta

. Cipla gets approval to sell its version of Truvada in India. Mumbai: The Hindu BusinessLine. Available from: https://www.thehindubusinessline.com/companies/cipla-gets-approval-to-sell-its-version-of-truvada-in-india/article8637483.ece (2016, accessed 1 March 2023).

Home – YRGCARE [Internet]. Chennai: YRGCARE. Available from: https://yrgcare.org/ (avccessed 16 March 2023).

Boda

. APSACS introduces HIV preventive medicine in State. Vijayawada: The Hindu. Available from: https://www.thehindu.com/news/national/andhra-pradesh/apsacs-introduces-hiv-preventive-medicine-in-state/article65612681.ece (2022, accesed 7 July 2022).

Sekhon

Cartwright

Francis

. Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Serv Res 2017; 17(1): 88.

10.

Sun

Dai

, et al. Increasing awareness of HIV pre‐exposure prophylaxis (PrEP) and willingness to use HIV PrEP among men who have sex with men: a systematic review and meta‐analysis of global data. J Int AIDS Soc 2022; 25(3). DOI: 10.1002/jia2.25883

11.

Uthappa

Allam

Pant

, et al. Pre-exposure prophylaxis: awareness, acceptability and risk compensation behaviour among men who have sex with men and the transgender population. HIV Med 2018; 19(4): 243–251.

12.

Belludi

McFall

Solomon

, et al. Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: results from a multi-city cross-sectional survey. PLOS ONE 2021; 16(2): e0247352.

13.

Chakrapani

Shaikh

Arumugam

, et al. Factors influencing willingness to use human immunodeficiency virus preexposure prophylaxis among transgender women in India. Transgend Health 2021; 6(2): 64–73.

14.

Chakrapani

Newman

Shunmugam

, et al. PrEP eligibility, HIV risk perception, and willingness to use PrEP among high-risk men who have sex with men in India: a cross-sectional survey. AIDS Care 2022; 34(3): 301–309.

15.

National AIDS Control Organization . National integrated biological and behavioural surveillance (IBBS) 2014-15: high risk groups. New Delhi: NACO, Ministry of Health and Family Welfare, Government of India, p. 278. Available from: http://naco.gov.in/sites/default/files/IBBS_Report_2014-15.pdf (2015, accessed 10 September 2021).

16.

National AIDS Control Organization . National integrated biological and behavioural surveillance (IBBS), hijras/transgender people, India 2014-15. New Delhi: NACO, Ministry of Health and Family Welfare, Government of India, p. 130. Available from: http://naco.gov.in/sites/default/files/TG-IBBS_ReportPrint_text_Edited.pdf (2016, accessed 20 March 2021).

17.

National AIDS Control Organization . Operational guidelines for implementing HIV targeted interventions among men who have sex with men in India: guidelines for CBOs/NGOs, SACS and TSUs. New Delhi: National AIDS Control Organization, p. 190. Available from: http://naco.gov.in/sites/default/files/MSM-OG.pdf (2016, accessed 18 April 2021).

18.

National AIDS Control Organization . Operational guidelines for implementing targeted interventions among hijras and transgender people in India: guidelines for CBOs/NGOs and SACS/TSU. New Delhi: National AIDS Control Organization, p. 161. Available from: http://naco.gov.in/sites/default/files/TG-_OG_(new).pdf (2016, accessed 18 April 2021).

19.

Delhi State AIDS Control Society . Targeted intervention project. New Delhi: Delhi State AIDS Control Society. Available from: http://health.delhigovt.nic.in/wps/wcm/connect/doit_dsacs/DSACS/Home/Targeted+Intervention+Project (2020, accessed 20 March 2021).

20.

Sharma

. Revised Kuppuswamy’s socioeconomic status scale: explained and updated. Indian Pediatr 2017; 54(10): 867–870.

21.

Tuot

Mwai

, et al. Awareness and willingness to use HIV pre-exposure prophylaxis among men who have sex with men in low- and middle-income countries: a systematic review and meta-analysis. J Int AIDS Soc 2017; 20(1): 21580.

22.

Chakrapani

Newman

Shunmugam

, et al. Acceptability of HIV pre-exposure prophylaxis (PrEP) and implementation challenges among men who have sex with men in India: a qualitative investigation. AIDS Patient Care STDs 2015; 29(10): 569–577.

23.

Kahle

Sullivan

Stephenson

. Functional knowledge of pre-exposure prophylaxis for HIV prevention among participants in a web-based survey of sexually active gay, bisexual, and other men who have sex with men: cross-sectional study. JMIR Public Health Surveill 2018; 4(1): e13.

24.

Iniesta

Álvarez-del Arco

García-Sousa

, et al. Awareness, knowledge, use, willingness to use and need of pre-exposure prophylaxis (PrEP) during world gay pride 2017. PLOS ONE 2018; 13(10): e0204738.

25.

Walsh

. Applying the information–motivation–behavioral skills model to understand PrEP intentions and use among men who have sex with men. AIDS Behav 2019; 23(7): 1904–1916.

26.

Cui

Huang

Zhang

, et al. Low awareness of and willingness to use PrEP in the Chinese YMSM: an alert in YMSM HIV prevention. HIV Med 2021; 22(3): 185–193.

27.

Yan

Wilson

, et al. Awareness and willingness to use HIV pre-exposure prophylaxis (PrEP) among trans women in China: a community-based survey. AIDS Behav 2021; 25(3): 866–874.

28.

Chakrapani

Shunmugam

Rawat

, et al. Acceptability of HIV pre-exposure prophylaxis among transgender women in India: a qualitative investigation. AIDS Patient Care STDs 2020; 34(2): 92–98.

29.

Ramanaik

Sinha

Mukherjee

, et al. Acceptability of PrEP among MSM and transgender communities—qualitative findings from two metropolitan cities in India. PLOS ONE 2023; 18(2): e0281984.

30.

Eisingerich

Wheelock

Gomez

, et al. Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study. PLoS ONE 2012; 7(1): e28238.

31.

Chakrapani

Newman

Cameron

, et al. Willingness to use pre-exposure prophylaxis (PrEP) and preferences among men who have sex with men in Mumbai and Chennai, India: a discrete choice experiment. AIDS Behav 2021; 25(10): 3074–3084.

32.

Knox

Kutner

Shiau

, et al. Assessing the information-motivation-behavioral skills model to predict pre-exposure prophylaxis adherence among black men who have sex with men and transgender women in a community setting in New York City. AIDS Behav 2022; 26(7): 2494–2502.

33.

Reza-Paul

Lazarus

Doshi

, et al. Prioritizing risk in preparation for a demonstration project: a mixed methods feasibility study of oral pre-exposure prophylaxis (PREP) among female sex workers in South India. PLoS ONE 2016; 11(11): e0166889.

34.

Sahay

Verma

Shewale

, et al. Understanding issues around use of oral pre exposure prophylaxis among female sex workers in India. BMC Infect Dis 2021; 21(1): 930.

35.

Draper

Fowkes

FJI

, et al. Willingness to use HIV pre-exposure prophylaxis among gay men, other men who have sex with men and transgender women in Myanmar. J Int AIDS Soc 2017; 20(1): 21885.

36.

Yang

Chariyalertsak

Wongthanee

, et al. Acceptability of pre-exposure prophylaxis among men who have sex with men and transgender women in Northern Thailand. PLoS ONE 2013; 8(10): e76650.

37.

In danger: UNAIDS global AIDS update 2022. Geneva: Joint United Nations Programme on HIV/AIDS, p. 373. Available from: https://www.unaids.org/sites/default/files/media_asset/2022-global-aids-update_en.pdf (2022, accessed 24 October 2022).

38.

Haldar

Reza-Paul

Daniel

, et al. A rapid review of pre-exposure prophylaxis for HIV in the Asia–Pacific region: recommendations for scale up and future directions. Sex Health 2021; 18(1): 31–40.

39.

Traeger

Schroeder

Wright

, et al. Effects of pre-exposure prophylaxis for the prevention of human immunodeficiency virus infection on sexual risk behavior in men who have sex with men: a systematic review and meta-analysis. Clin Infect Dis 2018; 67(5): 676–686.

40.

Reza-Paul

Lazarus

Jana

, et al. Community inclusion in PrEP demonstration projects: lessons for scaling up. Gates Open Res 2019; 3: 1504.

41.

Phanuphak

Sungsing

Jantarapakde

, et al. Princess PrEP program: the first key population-led model to deliver pre-exposure prophylaxis to key populations by key populations in Thailand. Sex Health 2018; 15(6): 542–555.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.45 MB

0.25 MB